(-)-Xanthatin induces the prolonged expression of C-fos through an N-acetyl-L-cysteine (NAC)-sensitive mechanism in human breast cancer MDA-MB-231 cells

Shuso Takeda, Hajime Nishimura, Kuniyoshi Koyachi, Kenji Matsumoto, Kazutaka Yoshida, Yoshiko Okamoto, Toshiaki Amamoto, Mitsuru Shindo, Hironori Aramaki

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

We reported that (-)-xanthatin, a xanthanolide sesquiterpene lactone present in the Cocklebur plant, exhibited potent anti-proliferative effects on human breast cancer cells, in which GADD45γ, a novel tumor suppressor gene, was induced. Mechanistically, topoisomerase IIα (Topo IIα) inhibition by (-)-xanthatin was shown to be the upstream trigger that stimulated the expression of GADD45γ mRNA and concomitantly produced reactive oxygen species (ROS) to maintain this expression. Since the anticancer drug etoposide, a selective Topo IIα inhibitor, has also been shown to induce intracellular ROS, (-)-xanthatin may exert its anti-proliferative effects on cancer cells in a similar manner to those of etoposide. In the present study, to generalize its applicability to cancer therapy, we further investigated the biological activities of (-)-xanthatin by comparing its activities to those of the established anti-cancer drug etoposide. After the exposure of breast cancer cells to (-)-xanthatin or etoposide, a prolonged and marked up-regulation in the expression of c-fos, a proapoptotic molecule, was detected together with GADD45γ; and the expression of these molecules was stabilized by ROS and abrogated by the pretreatment with N-acetyl-L-cysteine (NAC), a potent ROS scavenger. (-)-Xanthatin in particular exhibited stronger antiproliferative potential than that of etoposide, which underlies the marked induction of c-fos/GADD45γ and ROS production.

Original languageEnglish
Pages (from-to)547-557
Number of pages11
JournalJournal of Toxicological Sciences
Volume38
Issue number4
DOIs
Publication statusPublished - Aug 1 2013

Fingerprint

Acetylcysteine
Etoposide
Reactive Oxygen Species
Breast Neoplasms
Cells
Xanthium
Topoisomerase II Inhibitors
Neoplasms
Type II DNA Topoisomerase
Molecules
Sesquiterpenes
Lactones
Bioactivity
Tumor Suppressor Genes
Pharmaceutical Preparations
xanthatin
Tumors
Up-Regulation
Genes
Messenger RNA

All Science Journal Classification (ASJC) codes

  • Toxicology

Cite this

(-)-Xanthatin induces the prolonged expression of C-fos through an N-acetyl-L-cysteine (NAC)-sensitive mechanism in human breast cancer MDA-MB-231 cells. / Takeda, Shuso; Nishimura, Hajime; Koyachi, Kuniyoshi; Matsumoto, Kenji; Yoshida, Kazutaka; Okamoto, Yoshiko; Amamoto, Toshiaki; Shindo, Mitsuru; Aramaki, Hironori.

In: Journal of Toxicological Sciences, Vol. 38, No. 4, 01.08.2013, p. 547-557.

Research output: Contribution to journalArticle

Takeda, Shuso ; Nishimura, Hajime ; Koyachi, Kuniyoshi ; Matsumoto, Kenji ; Yoshida, Kazutaka ; Okamoto, Yoshiko ; Amamoto, Toshiaki ; Shindo, Mitsuru ; Aramaki, Hironori. / (-)-Xanthatin induces the prolonged expression of C-fos through an N-acetyl-L-cysteine (NAC)-sensitive mechanism in human breast cancer MDA-MB-231 cells. In: Journal of Toxicological Sciences. 2013 ; Vol. 38, No. 4. pp. 547-557.
@article{fb4a5a87b4ae4f8b9bcf5bb05cbff820,
title = "(-)-Xanthatin induces the prolonged expression of C-fos through an N-acetyl-L-cysteine (NAC)-sensitive mechanism in human breast cancer MDA-MB-231 cells",
abstract = "We reported that (-)-xanthatin, a xanthanolide sesquiterpene lactone present in the Cocklebur plant, exhibited potent anti-proliferative effects on human breast cancer cells, in which GADD45γ, a novel tumor suppressor gene, was induced. Mechanistically, topoisomerase IIα (Topo IIα) inhibition by (-)-xanthatin was shown to be the upstream trigger that stimulated the expression of GADD45γ mRNA and concomitantly produced reactive oxygen species (ROS) to maintain this expression. Since the anticancer drug etoposide, a selective Topo IIα inhibitor, has also been shown to induce intracellular ROS, (-)-xanthatin may exert its anti-proliferative effects on cancer cells in a similar manner to those of etoposide. In the present study, to generalize its applicability to cancer therapy, we further investigated the biological activities of (-)-xanthatin by comparing its activities to those of the established anti-cancer drug etoposide. After the exposure of breast cancer cells to (-)-xanthatin or etoposide, a prolonged and marked up-regulation in the expression of c-fos, a proapoptotic molecule, was detected together with GADD45γ; and the expression of these molecules was stabilized by ROS and abrogated by the pretreatment with N-acetyl-L-cysteine (NAC), a potent ROS scavenger. (-)-Xanthatin in particular exhibited stronger antiproliferative potential than that of etoposide, which underlies the marked induction of c-fos/GADD45γ and ROS production.",
author = "Shuso Takeda and Hajime Nishimura and Kuniyoshi Koyachi and Kenji Matsumoto and Kazutaka Yoshida and Yoshiko Okamoto and Toshiaki Amamoto and Mitsuru Shindo and Hironori Aramaki",
year = "2013",
month = "8",
day = "1",
doi = "10.2131/jts.38.547",
language = "English",
volume = "38",
pages = "547--557",
journal = "Journal of Toxicological Sciences",
issn = "0388-1350",
publisher = "Japanese Society of Toxicological Sciences",
number = "4",

}

TY - JOUR

T1 - (-)-Xanthatin induces the prolonged expression of C-fos through an N-acetyl-L-cysteine (NAC)-sensitive mechanism in human breast cancer MDA-MB-231 cells

AU - Takeda, Shuso

AU - Nishimura, Hajime

AU - Koyachi, Kuniyoshi

AU - Matsumoto, Kenji

AU - Yoshida, Kazutaka

AU - Okamoto, Yoshiko

AU - Amamoto, Toshiaki

AU - Shindo, Mitsuru

AU - Aramaki, Hironori

PY - 2013/8/1

Y1 - 2013/8/1

N2 - We reported that (-)-xanthatin, a xanthanolide sesquiterpene lactone present in the Cocklebur plant, exhibited potent anti-proliferative effects on human breast cancer cells, in which GADD45γ, a novel tumor suppressor gene, was induced. Mechanistically, topoisomerase IIα (Topo IIα) inhibition by (-)-xanthatin was shown to be the upstream trigger that stimulated the expression of GADD45γ mRNA and concomitantly produced reactive oxygen species (ROS) to maintain this expression. Since the anticancer drug etoposide, a selective Topo IIα inhibitor, has also been shown to induce intracellular ROS, (-)-xanthatin may exert its anti-proliferative effects on cancer cells in a similar manner to those of etoposide. In the present study, to generalize its applicability to cancer therapy, we further investigated the biological activities of (-)-xanthatin by comparing its activities to those of the established anti-cancer drug etoposide. After the exposure of breast cancer cells to (-)-xanthatin or etoposide, a prolonged and marked up-regulation in the expression of c-fos, a proapoptotic molecule, was detected together with GADD45γ; and the expression of these molecules was stabilized by ROS and abrogated by the pretreatment with N-acetyl-L-cysteine (NAC), a potent ROS scavenger. (-)-Xanthatin in particular exhibited stronger antiproliferative potential than that of etoposide, which underlies the marked induction of c-fos/GADD45γ and ROS production.

AB - We reported that (-)-xanthatin, a xanthanolide sesquiterpene lactone present in the Cocklebur plant, exhibited potent anti-proliferative effects on human breast cancer cells, in which GADD45γ, a novel tumor suppressor gene, was induced. Mechanistically, topoisomerase IIα (Topo IIα) inhibition by (-)-xanthatin was shown to be the upstream trigger that stimulated the expression of GADD45γ mRNA and concomitantly produced reactive oxygen species (ROS) to maintain this expression. Since the anticancer drug etoposide, a selective Topo IIα inhibitor, has also been shown to induce intracellular ROS, (-)-xanthatin may exert its anti-proliferative effects on cancer cells in a similar manner to those of etoposide. In the present study, to generalize its applicability to cancer therapy, we further investigated the biological activities of (-)-xanthatin by comparing its activities to those of the established anti-cancer drug etoposide. After the exposure of breast cancer cells to (-)-xanthatin or etoposide, a prolonged and marked up-regulation in the expression of c-fos, a proapoptotic molecule, was detected together with GADD45γ; and the expression of these molecules was stabilized by ROS and abrogated by the pretreatment with N-acetyl-L-cysteine (NAC), a potent ROS scavenger. (-)-Xanthatin in particular exhibited stronger antiproliferative potential than that of etoposide, which underlies the marked induction of c-fos/GADD45γ and ROS production.

UR - http://www.scopus.com/inward/record.url?scp=84879611485&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84879611485&partnerID=8YFLogxK

U2 - 10.2131/jts.38.547

DO - 10.2131/jts.38.547

M3 - Article

C2 - 23824011

AN - SCOPUS:84879611485

VL - 38

SP - 547

EP - 557

JO - Journal of Toxicological Sciences

JF - Journal of Toxicological Sciences

SN - 0388-1350

IS - 4

ER -